These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16958512)

  • 1. Convergent approaches for the synthesis of the antitumoral peptide, Kahalalide F. Study of orthogonal protecting groups.
    Gracia C; Isidro-Llobet A; Cruz LJ; Acosta GA; Alvarez M; Cuevas C; Giralt E; Albericio F
    J Org Chem; 2006 Sep; 71(19):7196-204. PubMed ID: 16958512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure determination of kahalalide F (1,2).
    López-Macià A; Jiménez JC; Royo M; Giralt E; Albericio F
    J Am Chem Soc; 2001 Nov; 123(46):11398-401. PubMed ID: 11707116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tandem mass spectrometry of kahalalides: identification of two new cyclic depsipeptides, kahalalide R and S from Elysia grandifolia.
    Tilvi S; Naik CG
    J Mass Spectrom; 2007 Jan; 42(1):70-80. PubMed ID: 17149796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kahalalide derivatives from the Indian sacoglossan mollusk Elysia grandifolia.
    Ashour M; Edrada R; Ebel R; Wray V; Wätjen W; Padmakumar K; Müller WE; Lin WH; Proksch P
    J Nat Prod; 2006 Nov; 69(11):1547-53. PubMed ID: 17125219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical defenses of the sacoglossan mollusk Elysia rufescens and its host Alga bryopsis sp.
    Becerro MA; Goetz G; Paul VJ; Scheuer PJ
    J Chem Ecol; 2001 Nov; 27(11):2287-99. PubMed ID: 11817082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kahalalides V-Y isolated from a Hawaiian collection of the sacoglossan mollusk Elysia rufescens.
    Rao KV; Na MK; Cook JC; Peng J; Matsumoto R; Hamann MT
    J Nat Prod; 2008 May; 71(5):772-8. PubMed ID: 18407693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugation of Kahalalide F with gold nanoparticles to enhance in vitro antitumoral activity.
    Hosta L; Pla-Roca M; Arbiol J; López-Iglesias C; Samitier J; Cruz LJ; Kogan MJ; Albericio F
    Bioconjug Chem; 2009 Jan; 20(1):138-46. PubMed ID: 19072538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I clinical and pharmacokinetic study of kahalalide F administered weekly as a 1-hour infusion to patients with advanced solid tumors.
    Pardo B; Paz-Ares L; Tabernero J; Ciruelos E; García M; Salazar R; López A; Blanco M; Nieto A; Jimeno J; Izquierdo MA; Trigo JM
    Clin Cancer Res; 2008 Feb; 14(4):1116-23. PubMed ID: 18281545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total solid-phase synthesis of marine cyclodepsipeptide IB-01212.
    Cruz LJ; Cuevas C; Cañedo LM; Giralt E; Albericio F
    J Org Chem; 2006 Apr; 71(9):3339-44. PubMed ID: 16626112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship of kahalalide F synthetic analogues.
    Jiménez JC; López-Macià A; Gracia C; Varón S; Carrascal M; Caba JM; Royo M; Francesch AM; Cuevas C; Giralt E; Albericio F
    J Med Chem; 2008 Aug; 51(16):4920-31. PubMed ID: 18672864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient solid-phase synthesis of FK228 analogues as potent antitumoral agents.
    Di Maro S; Pong RC; Hsieh JT; Ahn JM
    J Med Chem; 2008 Nov; 51(21):6639-41. PubMed ID: 18839938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationship of cytotoxic marine cyclodepsipeptide IB-01212 analogues.
    Cruz LJ; Francesch A; Cuevas C; Albericio F
    ChemMedChem; 2007 Jul; 2(7):1076-84. PubMed ID: 17514692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward the total synthesis of onchidin, a cytotoxic cyclic depsipeptide from a mollusc.
    Kobayashi S; Kobayashi J; Yazaki R; Ueno M
    Chem Asian J; 2007 Jan; 2(1):135-44. PubMed ID: 17441146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kahalalides: Bioactive Peptides from a Marine Mollusk Elysia rufescens and Its Algal Diet Bryopsis sp.(1).
    Hamann MT; Otto CS; Scheuer PJ; Dunbar DC
    J Org Chem; 1996 Sep; 61(19):6594-6600. PubMed ID: 11667527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kahalalide F and ES285: potent anticancer agents from marine molluscs.
    Faircloth G; Cuevas C
    Prog Mol Subcell Biol; 2006; 43():363-79. PubMed ID: 17153351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new depsipeptide from the sacoglossan mollusk Elysia ornata and the green alga Bryopsis species.
    Horgen FD; delos Santos DB; Goetz G; Sakamoto B; Kan Y; Nagai H; Scheuer PJ
    J Nat Prod; 2000 Jan; 63(1):152-4. PubMed ID: 10650101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mebamamide C, a deoxy analogue of mebamamides in Bryopsis marine green algae and Elysia sacoglossan mollusks.
    Komori S; Yamabe S; Matsuta R; Yamazaki Y; Fukuoka M; Sato S; Takada K
    Biosci Biotechnol Biochem; 2024 Mar; 88(4):399-404. PubMed ID: 38271606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances and limitations in the application of kahalalides for the control of cancer.
    Wyer S; Townsend DM; Ye Z; Kourtidis A; Choo YM; de Barros ALB; Donia MS; Hamann MT
    Biomed Pharmacother; 2022 Apr; 148():112676. PubMed ID: 35149387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical and enzymatic stability of a cyclic depsipeptide, the novel, marine-derived, anti-cancer agent kahalalide F.
    Sparidans RW; Stokvis E; Jimeno JM; López-Lázaro L; Schellens JH; Beijnen JH
    Anticancer Drugs; 2001 Aug; 12(7):575-82. PubMed ID: 11487713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kahalalide K: A new cyclic depsipeptide from the hawaiian green alga bryopsis species.
    Kan Y; Fujita T; Sakamoto B; Hokama Y; Nagai H
    J Nat Prod; 1999 Aug; 62(8):1169-72. PubMed ID: 10479330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.